Paredes R - Search Results

1

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.

Carr A, Mackie NE, Paredes R, Ruxrungtham K. Carr A, et al. Among authors: paredes r. Antivir Ther. 2023 Oct;28(5):13596535231201162. doi: 10.1177/13596535231201162. Antivir Ther. 2023. PMID: 37749751 Free article. Review.

2

New antiretroviral drugs and approaches to HIV treatment.

Paredes R, Clotet B. Paredes R, et al. AIDS. 2003;17 Suppl 4:S85-96. doi: 10.1097/00002030-200317004-00010. AIDS. 2003. PMID: 15080184 Review. No abstract available.

3

Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.

Negredo E, Paredes R, Peraire J, Pedrol E, Côté H, Gel S, Fumoz CR, Ruiz L, Abril V, Rodriguez de Castro E, Ochoa C, Martinez-Picado J, Montaner J, Rey-Joly C, Clotet B; Swatch Study Team. Negredo E, et al. Among authors: paredes r. Antivir Ther. 2004 Dec;9(6):889-93. Antivir Ther. 2004. PMID: 15651747 Clinical Trial.

4

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

Ruiz L, Paredes R, Gómez G, Romeu J, Domingo P, Pérez-Alvarez N, Tambussi G, Llibre JM, Martínez-Picado J, Vidal F, Fumaz CR, Clotet B; TIBET Study Group. Ruiz L, et al. Among authors: paredes r. AIDS. 2007 Jan 11;21(2):169-78. doi: 10.1097/QAD.0b013e328011033a. AIDS. 2007. PMID: 17197807 Clinical Trial.

5

Clinical management of HIV-1 resistance.

Paredes R, Clotet B. Paredes R, et al. Antiviral Res. 2010 Jan;85(1):245-65. doi: 10.1016/j.antiviral.2009.09.015. Epub 2009 Oct 4. Antiviral Res. 2010. PMID: 19808056 Review.

6

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.

Codoñer FM, Pou C, Thielen A, García F, Delgado R, Dalmau D, Santos JR, Buzón MJ, Martínez-Picado J, Alvarez-Tejado M, Clotet B, Ruiz L, Paredes R. Codoñer FM, et al. Among authors: paredes r. Antiviral Res. 2010 Dec;88(3):281-6. doi: 10.1016/j.antiviral.2010.09.016. Epub 2010 Sep 29. Antiviral Res. 2010. PMID: 20883724

7

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.

Tural C, Solà R, Alvarez NP, Moltó J, Sánchez M, Zamora AM, Ornelas A, Laguno M, González J, von Wichmann MÁ, Téllez MJ, Paredes R, Clotet B; CORAL-2 study group. Tural C, et al. Among authors: paredes r. Antivir Ther. 2011;16(6):833-41. doi: 10.3851/IMP1837. Antivir Ther. 2011. PMID: 21900715 Clinical Trial.

8

2011 update of the drug resistance mutations in HIV-1.

Johnson VA, Calvez V, Günthard HF, Paredes R, Pillay D, Shafer R, Wensing AM, Richman DD. Johnson VA, et al. Among authors: paredes r. Top Antivir Med. 2011 Nov;19(4):156-64. Top Antivir Med. 2011. PMID: 22156218 Free PMC article. Review.

9

Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study.

Tu E, Swenson LC, Land S, Pett S, Emery S, Marks K, Kelleher AD, Kaye S, Kaiser R, Schuelter E, Harrigan R; MARCH Laboratory Group and the MARCH Study Group. Tu E, et al. J Clin Microbiol. 2013 Jul;51(7):2063-71. doi: 10.1128/JCM.00510-13. Epub 2013 Apr 17. J Clin Microbiol. 2013. PMID: 23596247 Free PMC article.

10

Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.

Paredes R, Marconi VC, Lockman S, Abrams EJ, Kuhn L. Paredes R, et al. J Infect Dis. 2013 Jun 15;207 Suppl 2(Suppl 2):S93-100. doi: 10.1093/infdis/jit110. J Infect Dis. 2013. PMID: 23687295 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

741 results

Search Page

Filters